FXall Adds Three Banks for Options Pricing

manhattan-skyline
FXall was recently acquired by Thomson Reuters in a heavyweight, if quiet, transaction.

The three banks, among the largest in the world, join Bank of America Merrill Lynch and Credit Suisse on the platform, which provides auto-pricing from liquidity providers in line with increasing the electronic-based trading of options.

"The FXall Multibank Options trading platform will open up a new channel for us to serve our clients," says Kayhan Mirza, global head of FX options at JPMorgan. "As the market evolves towards a more electronic means of execution, FXall is a strategic partner in helping to broaden the distribution of our electronic products. We are pleased to offer liquidity through this new trading venue, and welcome the greater choice and improved access to liquidity that this will bring."

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

‘Feature, not a bug’: Bloomberg makes the case for Figi

Bloomberg created the Figi identifier, but ceded all its rights to the Object Management Group 10 years ago. Here, Bloomberg’s Richard Robinson and Steve Meizanis write to dispel what they believe to be misconceptions about Figi and the FDTA.

Where have all the exchange platform providers gone?

The IMD Wrap: Running an exchange is a profitable business. The margins on market data sales alone can be staggering. And since every exchange needs a reliable and efficient exchange technology stack, Max asks why more vendors aren’t diving into this space.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here